Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’s Unapproved Drug Initiative, according to an analysis released today by Vizient. 

Launched in 2006, the initiative requires drugs marketed before FDA began regulating drug safety and efficacy in 1938 to receive FDA approval to stay on the market. 

“Depending on the approval, manufacturers receive periods of exclusivity ranging from three to seven years,” said Dan Kistner, group senior vice president for pharmacy solutions at Vizient. “If a patent is awarded, the manufacturer could have market exclusivity for 20 years.” 

The study looks at four drugs approved through the UDI process since 2013, and estimates they will increase U.S. health care spending by $20.25 billion during their market exclusivity periods. With 19 additional drugs poised to go through this approval process, “the combined impact of the higher costs for these 23 drugs could be $29 billion,” Kistner said.
 

Related News Articles

Headline
The AHA has released several resources that can be used to educate members of Congress and community stakeholders about the potential effects of harmful cuts…
Perspective
Public
The House Energy & Commerce Committee in just over a week is expected to mark up its portion of the budget reconciliation bill to enact key pieces of…
Headline
A study published April 28 by Health Affairs Scholar found low-income adults living in states with Medicaid expansion experienced an average 9.5% relative…
Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge…
News
The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options…
Perspective
Public
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla…